News

Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo” or the “Company”) (OTCQX: SONX), a leading dental technology company and developer of the…

1 year ago

Outset Medical Reports Second Quarter 2024 Financial Results

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology…

1 year ago

Medexus Announces Strong Fiscal Q1 2025 Results

Fiscal Q1 2025 revenue of $27.3 million, net income of $2.0 million, operating income of $4.0 million, and Adjusted EBITDA*…

1 year ago

MARPAI REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS

Company continues to drive towards profitability TAMPA, Fla., Aug. 7, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology…

1 year ago

Waystar Reports Second Quarter 2024 Results

Revenue growth of 20% year-over-year Net loss of $27.7 million and non-GAAP net income of $5.0 million Net loss margin…

1 year ago

Epilog Partners Acquires Care Connectors Medical Group, a Leading Value-Based Care Enablement Platform

DALLAS and NEWPORT BEACH, Calif., Aug. 7, 2024 /PRNewswire/ -- Epilog Partners, a private equity platform built by investors, operators…

1 year ago

IONETIX closes financing led by Tees River and Eli Lilly and Company

LANSING, Mich., Aug. 7, 2024 /PRNewswire/ -- IONETIX Corporation ("Ionetix"), a leading cyclotron technology innovator and isotope manufacturer for diagnostic…

1 year ago

Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth

OEMs Leading the Charge with AI-Equipped Technology and Novel Business Strategies SAN ANTONIO, Aug. 7, 2024 /PRNewswire/ -- The diabetes…

1 year ago

Tres Health Launches TresTech™ Digital Health Platforms

BOCA RATON, Fla., Aug. 7, 2024 /PRNewswire/ -- Tres Health, an alternative health insurance company, has moved into the Insurtech space…

1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2024

Reports Net Revenues of $182.4 Million for the Three Months Ended June 30, 2024RANCHO CUCAMONGA, CA / ACCESSWIRE / August…

1 year ago